Caitong International Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Caitong International Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27	Closed	-$390	–	3142
2026 Q1	$390	Sell	27 -4,204	-99%	-$60.3K	﹤0.01%	1730
2025 Q4	$60.2K	Buy	+4,231	New	+$41.6K	0.01%	633
2025 Q3	–	Sell	-1,669	Closed	-$9.56K	–	2146
2025 Q2	$9.56K	Buy	1,669 +101	+6%	+$652	0.01%	747
2025 Q1	$12.8K	Buy	1,568 +1,217	+347%	+$11.3K	0.01%	819
2024 Q4	$3.31K	Buy	+351	New	+$3.65K	﹤0.01%	1092

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caitong International Asset Management's FOLD Position: Q2 2026 in Review

Caitong International Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 27 shares — an estimated $390 sold.

Caitong International Asset Management first reported a position in FOLD in Q4 2024 and held it in 5 quarters. The position peaked at $60.2K in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Caitong International Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 27 Amicus Therapeutics shares in Q2 2026, an estimated $390.
Caitong International Asset Management first reported a position in Amicus Therapeutics in Q4 2024 and held it in 5 quarters.
Caitong International Asset Management's Amicus Therapeutics position peaked at $60.2K in Q4 2025.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.